Job posting has expired
Sr. Director, Clinical Science
Apellis Pharmaceuticals, Inc. | |
life insurance, flex time, 401(k)
| |
United States | |
100 5th Avenue (Show on map) | |
Oct 29, 2025 | |
|
Position Summary: The Sr. Director, Clinical Science, is a key member of our clinical development team, contributing to and providing leadership on the development and execution of the clinical strategy for current and future clinical programs. The successful candidate will lead Clinical Scientists and either directly or indirectly oversee cross-functional teams including clinical operations, data management, biostatistics, regulatory affairs, and medical affairs to ensure successful clinical program execution. The incumbent will have the responsibility, in conjunction with Medical Director Leads, to develop comprehensive clinical development plans, provide scientific expertise, and ensure efficient delivery of clinical trials in a matrixed environment. Preferred job location: Waltham, MA. Remote candidates will be considered on a case-by-case basis or relocation may be provided. Key Responsibilities Include:
Education, Registration & Certification:
Experience:
Skills, Knowledge & Abilities:
Physical Demands and Work Environment:
Travel Requirements:
Benefits and Perks: Base salary for this role will consider multiple factors, including but not limited to, candidate qualifications, relevant expertise, specialized skills, and industry experience in complement-targeted therapies. The targeted base salary range for this position is $242,000- $363,000 per year. This range represents the base salary only and reflects Apellis' commitment to competitive compensation within the biopharmaceutical industry. The final salary offered may vary based on individual qualifications, business needs, and current market conditions. Apellis offers a comprehensive benefits package, including a 401(k) plan with company match, inclusive family building benefits, flexible time off, summer and winter shutdowns, paid family leave, disability and life insurance, and more! Visit https://apellis.com/careers/benefits/ to learn more. Company Background: Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visithttp://apellis.comor follow us onTwitterandLinkedIn EEO Statement: Apellis is an equal opportunity employer and complies with all applicable federal, state and local fair employment practices laws. Apellis strictly prohibits and does not tolerate discrimination against employees, applicants or any other covered persons because of race, color, religion, creed, national origin or ancestry, ethnicity, sex (including pregnancy), gender (including gender nonconformity and status as a transgender or transsexual individual), age, physical or mental disability, citizenship, past, current or prospective service in the uniformed services, genetic information, marital status, AIDS/HIV status, smoker/nonsmoker, and occupational pneumoconiosis or any other characteristic protected under applicable federal, state or local law. For San Francisco postings: Pursuant to the San Francisco Fair Chance Ordinance, we will consider for employment qualified applicants with arrest and conviction records. Other Duties: Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice. | |
life insurance, flex time, 401(k)
Oct 29, 2025